Lv2
190 积分 2023-03-24 加入
Bruton tyrosine kinase inhibitors for multiple sclerosis
21天前
已完结
The Bruton’s Tyrosine Kinase Inhibitor Evobrutinib Demonstrates Superior Efficacy in Targeting Compartmentalized Neuroinflammation Compared to Anti-CD20 Treatment. (S16.004)
21天前
已关闭
Central TYK2 inhibition identifies TYK2 as a key neuroimmune modulator
22天前
已完结
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
1个月前
已完结
B-cell depletion in autoimmune diseases
1个月前
已完结
Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches
2个月前
已完结
Simulated single-cycle kinetics improves the design of surface plasmon resonance assays
2个月前
已完结
Selective and Potent Molecular Glue Degraders for NIMA‐related Kinase 7
2个月前
已完结
Synthesis and evaluation of 2-{[2-(4-hydroxyphenyl)-ethyl]amino}pyrimidine-5-carboxamide derivatives as novel STAT6 inhibitors
2个月前
已完结
Identification of 4-benzylamino-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5-carboxamide derivatives as potent and orally bioavailable STAT6 inhibitors
2个月前
已完结
皖公网安备34019202002308
